RARRES2 and metabolic disease: In this context, as chemerin directly relates to provoking insulin resistance and adiposity, other studies suggest that it can be considered as an interesting clinical indicator for metabolic disorders (Fatima et al., 2013[13]; Singh et al., 2018[42]).